Clinical Trials for EGFR Mutation Positive Advanced Non Small Cell Lung Cancer

Find clinical trials for egfr mutation positive advanced non small cell lung cancer. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC.

NCT ID: NCT06982924

This clinical trial is looking at the effectiveness and safety of a new treatment for patients with advanced non-small cell lung cancer (NSCLC) that has specific mutations. The researchers want to ...

Not yet recruiting

Phase: PHASE2 Type: interventional

ORIENT-31 Regimen in Combination with SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

NCT ID: NCT06775743

The ORIENT-31 trial is studying a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) who have a specific genetic mutation (EGFR mutation) and have not responded to...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions